Prostatic Adenoma
6
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
75%
3 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Efficacy of Hyaluronic Acid Injections on Functional Recovery After Surgery for Prostate Adenoma
Teverelix Evaluated in Advanced Prostate Cancer
Observational Study to Compare Two Prostate Laser Enucleation Techniques in Terms of Urinary Incontinence
Rezum I Pilot Study for Benign Prostatic Hyperplasia
Rezum FIM Optimization Study
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique